The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE

OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8

COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ASTERIAS BIOTHERAPEUTICS INC COM SER A 04624N107 6,449 1,641,025 SH   DFND 1 1,641,025 0 0
BIOTIME INC COM 09066L105 82,811 21,864,396 SH   DFND 1 21,864,396 0 0
CYNOSURE INC CL A 232577205 40,961 916,975 SH   DFND 1 916,975 0 0
IMPRIVATA INC COM 45323J103 7,554 668,526 SH   DFND 1 668,526 0 0
ISHARES TR RUSSELL 2000 ETF 464287655 28,155 250,000 SH   DFND 1 250,000 0 0
ONCOCYTE CORPORATION COM 68235C107 6,833 1,093,219 SH   DFND 1 1,093,219 0 0
MONSTER BEVERAGE CORP NEW COM 61174X109 238,207 1,599,136 SH   DFND 1 1,599,136 0 0
MALLINCKRODT PUB LTD CO SHS G5785G107 120,898 1,619,968 SH   DFND 1 1,619,968 0 0
STAAR SURGICAL CO COM PAR $0.01 852312305 61,739 8,646,923 SH   DFND 1 8,646,923 0 0